The effect of wet cupping therapy on the levels of blood lipids and grade of fatty liver in non-alcoholic patients.
Not Applicable
Recruiting
- Conditions
- on-alcoholic Fatty Liver Disease.Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT20180711040437N1
- Lead Sponsor
- Gonabad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
They do not have hyperlipidemia
They do not drink alcohol
They do not have a history of kidney failure and coronary artery diseases
In the last two months, they do not have wet cupping therapy and blood donation
They do not have a history of severe movement restrictions
Exclusion Criteria
Any treatment or intervention that is carried out during the study and affect the variables of the research.
Changes in the patient's condition so that it is not allowed to continue cupping therapy, such as pregnancy.
Patients' lack of satisfaction to continue their collaboration in the research project.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cholesterol. Timepoint: Before Intervention, One Month Later of second Wet Cupping Therapy. Method of measurement: Pars Azmoon kit and BT 3000 Device.;Triglyceride. Timepoint: Before Intervention, One Month Later of second Wet Cupping Therapy. Method of measurement: Pars Azmoon kit and BT 3000 Device.;Aspartate Aminotransferase Test. Timepoint: Before Intervention, One Month Later of second Wet Cupping Therapy. Method of measurement: Pars Azmoon kit and BT 3000 Device.
- Secondary Outcome Measures
Name Time Method Cholesterol Test. Timepoint: Before Intervention and One month later of Second Wet Cupping Therapy. Method of measurement: Pars Azmoon Kit and BT 3000 Device.;Triglyceride. Timepoint: Before Intervention and One month later of Second Wet Cupping Therapy. Method of measurement: Pars Azmoon Kit and BT 3000 Device.;Aspartat Aminotransferase Test. Timepoint: Before Intervention and One month later of Second Wet Cupping Therapy. Method of measurement: Pars Azmoon Kit and BT 3000 Device.